Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes

Clinical trial NCT05473806 · UNKNOWN

Trial details

NCT number: NCT05473806
Sponsor: Seung Up Kim
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis B, Chronic Fibrosis, Liver Diabetes Mellitus, Type 2

Start date: 2020-09-18
Primary completion: 2023-01-19
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.